{"id":138837,"date":"2026-10-30T19:45:57","date_gmt":"2026-10-30T10:45:57","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/2689-20261030-02_wp_earnings_guidance\/"},"modified":"2026-10-30T19:45:57","modified_gmt":"2026-10-30T10:45:57","slug":"2689-20261030-02_wp_earnings_guidance","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/","title":{"rendered":"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast"},"content":{"rendered":"<p>The company announced consolidated earnings guidance and dividend forecasts for the fiscal year ending June 2027. Interim sales are 80,285 million yen, interim ordinary income is 646 million yen, interim net income attributable to owners of parent is 355 million yen, 1 share basic interim net income is 0.43 yen. Full-year sales are 178,885 million yen, full-year ordinary income is 1,950 million yen, net income attributable to owners of parent for the year is 1,172 million yen, 1 share basic net income for the year is 130.30 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2689","jir_company_name":"OLBA DVx HEALTHCARE, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2689-20261030-02.pdf","jir_short_summary":"The company announced consolidated earnings guidance and dividend forecasts for the fiscal year ending June 2027. Interim sales are 80,285 million yen, interim ordinary income is 646 million yen, interim net income attributable to owners of parent is 355 million yen, 1 share basic interim net income is 0.43 yen. Full-year sales are 178,885 million yen, full-year ordinary income is 1,950 million yen, net income attributable to owners of parent for the year is 1,172 million yen, 1 share basic net income for the year is 130.30 yen.","jir_summary":"### Disclosure of Earnings Guidance and Assumptions\nThis document announces the consolidated earnings guidance and dividend forecast for the fiscal year ending June 2027. As an accounting assumption related to the integration, it reflects goodwill amortization and one-time expenses associated with the business combination with DVX. The applicable period is October 1, 2026 to June 30, 2027 (incorporating nine months of DVX), with an assumed acquisition date of September 30, 2026. Although market conditions remain uncertain due to rising raw material costs, foreign exchange and logistics expenses, the company aims to improve profitability by realizing integration benefits early.\n\n### Dividend Forecast and Shareholder Returns\nThe dividend forecast for the fiscal year ending June 2027 is 80 yen per share annually (80 yen at year-end, 0 yen at the end of the second quarter), the same amount as the previous fiscal year. The shareholder return policy prioritizes profit distribution while maintaining internal reserves as the basic policy.","jir_financial_highlights":"Sales (Interim): 80,285 (No difference from previous forecast A\u2192B)\nOperating Income (Interim): 669 (No difference from previous forecast A\u2192B)\nOrdinary Income (Interim): 646 (No difference from previous forecast A\u2192B)\nInterim Net Income Attributable to Owners of Parent: 355 (No difference from previous forecast A\u2192B)\nInterim Basic Net Income per Share: 43.09 (No difference from previous forecast A\u2192B)\nSales (Full-year): 178,885 (No difference from previous forecast A\u2192B)\nOrdinary Income (Full-year): 1,986 (No difference from previous forecast A\u2192B)\nNet Income Attributable to Owners of Parent (Full-year): 1,172 (No difference from previous forecast A\u2192B)\nBasic Net Income per Share (Full-year): 130.30 (No difference from previous forecast A\u2192B)","jir_category":"","jir_hashtags":"#OLBADVxHEALTHCARE, #EarningsGuidanceAndDividendForecast, #BusinessIntegration, #MedicalDevices","jir_key_figures":"Fiscal year ending June 2027 Interim Sales 80,285 million yen\nFiscal year ending June 2027 Interim Ordinary Income 646 million yen\nFiscal year ending June 2027 Interim Net Income Attributable to Owners of Parent 355 million yen\nFiscal year ending June 2027 Full-year Sales 178,885 million yen\nFiscal year ending June 2027 Full-year Ordinary Income 1,986 million yen\nFiscal year ending June 2027 Full-year Net Income Attributable to Owners of Parent 1,172 million yen\nFull-year Basic Net Income per Share 130.30 yen\nYear-end Dividend Forecast 80 yen","jir_meta_title":"OLBA DVx HEALTHCARE, Inc. Discloses Earnings Guidance and Dividend Forecast\uff5cFY ending June 2027","jir_meta_description":"OLBA DVx HEALTHCARE, Inc. has disclosed consolidated earnings guidance and a dividend forecast for the fiscal year ending June 2027. The outlook for interim and full-year sales and profits is provided together with assumptions related to the DVX integration. Year-end dividend is forecast at 80 yen, with an annual dividend of 80 yen.","jir_og_title":"OLBA DVx HEALTHCARE, Inc. Discloses Earnings Guidance and Dividend Forecast\uff5cFY ending June 2027","jir_og_description":"The company announced earnings guidance and a dividend forecast for the fiscal year ending June 2027, reflecting integration assumptions, one-time expenses and goodwill amortization, and presenting sales and profit outlooks.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58611,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-138837","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/\",\"name\":\"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-10-30T10:45:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/","url":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/","name":"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-10-30T10:45:57+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-2689\/ir\/2689-20261030-02_wp_earnings_guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Disclosure of Earnings Guidance and Dividend Forecast"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"58611","title":"OLBA HEALTHCARE HLDGS INC","ticker":"2689"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/138837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=138837"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/138837\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=138837"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=138837"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=138837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}